Molecular analysis of pericentrin gene (PCNT) in a series of 24 Seckel/microcephalic osteodysplastic primordial dwarfism type II (MOPD II) families - PubMed (original) (raw)
. 2010 Dec;47(12):797-802.
doi: 10.1136/jmg.2009.067298. Epub 2009 Jul 29.
D Geneviève, G Borck, C Baumann, G Baujat, E Bieth, P Edery, C Farra, M Gerard, D Héron, B Leheup, M Le Merrer, S Lyonnet, D Martin-Coignard, M Mathieu, C Thauvin-Robinet, A Verloes, L Colleaux, A Munnich, V Cormier-Daire
Affiliations
- PMID: 19643772
- DOI: 10.1136/jmg.2009.067298
Free article
Molecular analysis of pericentrin gene (PCNT) in a series of 24 Seckel/microcephalic osteodysplastic primordial dwarfism type II (MOPD II) families
M Willems et al. J Med Genet. 2010 Dec.
Free article
Abstract
Microcephalic osteodysplastic primordial dwarfism type II (MOPD II, MIM 210720) and Seckel syndrome (SCKL, MIM 210600) belong to the primordial dwarfism group characterised by intrauterine growth retardation, severe proportionate short stature, and pronounced microcephaly. MOPD II is distinct from SCKL by more severe growth retardation, radiological abnormalities, and absent or mild mental retardation. Seckel syndrome is associated with defective ATR dependent DNA damage signalling. In 2008, loss-of-function mutations in the pericentrin gene (PCNT) have been identified in 28 patients, including 3 SCKL and 25 MOPDII cases. This gene encodes a centrosomal protein which plays a key role in the organisation of mitotic spindles. The aim of this study was to analyse PCNT in a large series of SCKL-MOPD II cases to further define the clinical spectrum associated with PCNT mutations. Among 18 consanguineous families (13 SCKL and 5 MOPDII) and 6 isolated cases (3 SCKL and 3 MOPD II), 13 distinct mutations were identified in 5/16 SCKL and 8/8 MOPDII including five stop mutations, five frameshift mutations, two splice site mutations, and one apparent missense mutation affecting the last base of exon 19. Moreover, we demonstrated that this latter mutation leads to an abnormal splicing with a predicted premature termination of translation. The clinical analysis of the 5 SCKL cases with PCNT mutations showed that they all presented minor skeletal changes and clinical features compatible with MOPDII diagnosis. It is therefore concluded that, despite variable severity, MOPDII is a genetically homogeneous condition due to loss-of-function of pericentrin.
Similar articles
- Striking hematological abnormalities in patients with microcephalic osteodysplastic primordial dwarfism type II (MOPD II): a potential role of pericentrin in hematopoiesis.
Unal S, Alanay Y, Cetin M, Boduroglu K, Utine E, Cormier-Daire V, Huber C, Ozsurekci Y, Kilic E, Simsek Kiper OP, Gumruk F. Unal S, et al. Pediatr Blood Cancer. 2014 Feb;61(2):302-5. doi: 10.1002/pbc.24783. Epub 2013 Sep 17. Pediatr Blood Cancer. 2014. PMID: 24106199 - A novel homozygous mutation of the PCNT gene in a Chinese patient with microcephalic osteodysplastic primordial dwarfism type II.
Liu H, Tao N, Wang Y, Yang Y, He X, Zhang Y, Zhou Y, Liu X, Feng X, Sun M, Xu F, Su Y, Li L. Liu H, et al. Mol Genet Genomic Med. 2021 Sep;9(9):e1761. doi: 10.1002/mgg3.1761. Epub 2021 Jul 31. Mol Genet Genomic Med. 2021. PMID: 34331829 Free PMC article. - Majewski osteodysplastic primordial dwarfism type II (MOPD II) syndrome previously diagnosed as Seckel syndrome: report of a novel mutation of the PCNT gene.
Piane M, Della Monica M, Piatelli G, Lulli P, Lonardo F, Chessa L, Scarano G. Piane M, et al. Am J Med Genet A. 2009 Nov;149A(11):2452-6. doi: 10.1002/ajmg.a.33035. Am J Med Genet A. 2009. PMID: 19839044 - Microcephalic Osteodysplastic Primordial Dwarfism Type II.
Duker A, Jackson A, Bober MB. Duker A, et al. 2021 Dec 30 [updated 2023 Mar 30]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2021 Dec 30 [updated 2023 Mar 30]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 34978779 Free Books & Documents. Review. - Microcephalic Osteodysplastic Primordial Dwarfism, Type II: a Clinical Review.
Bober MB, Jackson AP. Bober MB, et al. Curr Osteoporos Rep. 2017 Apr;15(2):61-69. doi: 10.1007/s11914-017-0348-1. Curr Osteoporos Rep. 2017. PMID: 28409412 Free PMC article. Review.
Cited by
- Microcephalic osteodysplastic primordial dwarfism type II is associated with global vascular disease.
Duker AL, Kinderman D, Jordan C, Niiler T, Baker-Smith CM, Thompson L, Parry DA, Carroll RS, Bober MB. Duker AL, et al. Orphanet J Rare Dis. 2021 May 20;16(1):231. doi: 10.1186/s13023-021-01852-y. Orphanet J Rare Dis. 2021. PMID: 34016138 Free PMC article. - C-Nap1 mutation affects centriole cohesion and is associated with a Seckel-like syndrome in cattle.
Floriot S, Vesque C, Rodriguez S, Bourgain-Guglielmetti F, Karaiskou A, Gautier M, Duchesne A, Barbey S, Fritz S, Vasilescu A, Bertaud M, Moudjou M, Halliez S, Cormier-Daire V, Hokayem JE, Nigg EA, Manciaux L, Guatteo R, Cesbron N, Toutirais G, Eggen A, Schneider-Maunoury S, Boichard D, Sobczak-Thépot J, Schibler L. Floriot S, et al. Nat Commun. 2015 Apr 23;6:6894. doi: 10.1038/ncomms7894. Nat Commun. 2015. PMID: 25902731 Free PMC article. - A novel role for the centrosomal protein, pericentrin, in regulation of insulin secretory vesicle docking in mouse pancreatic beta-cells.
Jurczyk A, Pino SC, O'Sullivan-Murphy B, Addorio M, Lidstone EA, Diiorio P, Lipson KL, Standley C, Fogarty K, Lifshitz L, Urano F, Mordes JP, Greiner DL, Rossini AA, Bortell R. Jurczyk A, et al. PLoS One. 2010 Jul 27;5(7):e11812. doi: 10.1371/journal.pone.0011812. PLoS One. 2010. PMID: 20676397 Free PMC article. - Mechanisms and pathways of growth failure in primordial dwarfism.
Klingseisen A, Jackson AP. Klingseisen A, et al. Genes Dev. 2011 Oct 1;25(19):2011-24. doi: 10.1101/gad.169037. Genes Dev. 2011. PMID: 21979914 Free PMC article. Review. - The leukemia-associated Rho guanine nucleotide exchange factor LARG is required for efficient replication stress signaling.
Beveridge RD, Staples CJ, Patil AA, Myers KN, Maslen S, Skehel JM, Boulton SJ, Collis SJ. Beveridge RD, et al. Cell Cycle. 2014;13(21):3450-9. doi: 10.4161/15384101.2014.956529. Cell Cycle. 2014. PMID: 25485589 Free PMC article.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous